<VariationArchive VariationID="831407" VariationName="NC_000012.12:g.(?_114394721)_(114394913_?)del" VariationType="Deletion" Accession="VCV000831407" Version="7" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-17" DateCreated="2020-04-15" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="820445" VariationID="831407">
      <GeneList>
        <Gene Symbol="TBX5" FullName="T-box transcription factor 5" GeneID="6910" HGNC_ID="HGNC:11604" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q24.21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="114353911" stop="114408442" display_start="114353911" display_stop="114408442" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="114791734" stop="114846246" display_start="114791734" display_stop="114846246" Strand="-" />
          </Location>
          <OMIM>601620</OMIM>
          <Haploinsufficiency last_evaluated="2020-07-29" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TBX5">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-07-29" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TBX5">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000012.12:g.(?_114394721)_(114394913_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q24.21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" innerStart="114832526" innerStop="114832718" display_start="114832526" display_stop="114832718" variantLength="193" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.(?_114832526)_(114832718_?)del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.(?_114832526)_(114832718_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000012.12:g.(?_114394721)_(114394913_?)del AND Aortic valve disease 2" Accession="RCV001031964" Version="7">
        <ClassifiedConditionList TraitSetID="8857">
          <ClassifiedCondition DB="MedGen" ID="C3542024">Aortic valve disease 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-08-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-08-20" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16917909</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8857" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17368" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Aortic valve disease 2</ElementValue>
                <XRef ID="MONDO:0013902" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AOVD2</ElementValue>
                <XRef Type="MIM" ID="614823" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18471" />
                <XRef ID="18471" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C3542024" DB="MedGen" />
              <XRef ID="MONDO:0013902" DB="MONDO" />
              <XRef Type="MIM" ID="614823" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2356526" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="NM_000192.3_12_Deletion (exon 6)|MedGen:CN143724" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001195271" DateUpdated="2024-06-09" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-08-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16917909</ID>
          </Citation>
          <Comment>Experimental studies and prediction algorithms are not available or were not evaluated for this variant, and the functional significance of this variant is currently unknown. This variant has been observed in individuals affected with clinical features of Holt-Oram syndrome (PMID: 16917909, Invitae). In at least one individual the variant was observed to be de novo. This variant is an in-frame deletion of the genomic region encompassing exon 6 of the TBX5 gene. It preserves the integrity of the reading frame. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TBX5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.11:g.(?_114832526)_(114832718_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN143724" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
          <SubmissionName>SUB6933794</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2356526" TraitType="Disease" MappingType="XRef" MappingValue="CN143724" MappingRef="MedGen">
        <MedGen CUI="C3542024" Name="Aortic valve disease 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

